In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

AstraZeneca licenses candidate to Flexion

Executive Summary

AstraZeneca PLC licensed one of its clinical development compounds to drug development start-up Flexion Therapeutics (attempts to take Big Pharma's shelved candidates through proof-of-concept faster and cheaper than the traditional development process). The deal has the possibility of expanding through the addition of more molecules if Flexion does well with the first one.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Reverse Licensing
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register